SeQuent Scientific Share Price Analyzed

On Thursday, November 27th, SeQuent Scientific’s stock jumped significantly, rising by 7.44% to reach ₹235.6 per share. This increase was driven by news that the company had officially set the date for a major company merger. While the stock is still a little lower than its highest point this year, there’s continued investor interest.

Key Points

• SeQuent Scientific stock increased 7.44% due to merger news.
• Stock is 9% below its 52-week high of ₹257.85.
• The merger involves combining SeQuent with Viyash Lifesciences.
• Record Dates set for the Viyash merger process.
• 3.22 million shares traded on NSE and BSE today.
• Merger details involve a 56:100 exchange ratio.

The company announced that December 8, 2025, has been chosen as the “Record Date 2” for the Viyash merger. This means that shareholders of Viyash will be able to receive shares from the SeQuent merger. The exchange ratio is 56 SeQuent shares for every 100 Viyash shares.

Previously, SeQuent and Viyash announced that the National Company Law Tribunal (NCLT) had approved the merger. A previous record date, November 1, 2025, was set to determine Viyash shareholders eligible for merger consideration shares. This previous ratio involved 47 Viyash shares for every one Viyash share.

“Strategic mergers like this indicate a growing confidence in SeQuent’s long-term growth potential.”